IBDEI3BE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1261,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^17^108
 ;;^UTILITY(U,$J,358.4,1262,0)
 ;;=CATEGORY III CODES^5^108
 ;;^UTILITY(U,$J,358.4,1263,0)
 ;;=TEAM CONFERENCE^20^108
 ;;^UTILITY(U,$J,358.4,1264,0)
 ;;=HOME HEALTH PROCEDURES^6^108
 ;;^UTILITY(U,$J,358.4,1265,0)
 ;;=INJECTION ADMINISTRATION^7^108
 ;;^UTILITY(U,$J,358.4,1266,0)
 ;;=ADAPTIVE BEHAVIOR ASSESSMENT^1^108
 ;;^UTILITY(U,$J,358.4,1267,0)
 ;;=ADAPTIVE BEHAVIOR TREATMENT^2^108
 ;;^UTILITY(U,$J,358.4,1268,0)
 ;;=ESTABLISHED PATIENT^1^109
 ;;^UTILITY(U,$J,358.4,1269,0)
 ;;=CONSULTATIONS-OUTPATIENT^3^109
 ;;^UTILITY(U,$J,358.4,1270,0)
 ;;=NEW PATIENT^2^109
 ;;^UTILITY(U,$J,358.4,1271,0)
 ;;=CONSULTATIONS-INPATIENT^4^109
 ;;^UTILITY(U,$J,358.4,1272,0)
 ;;=INITIAL HOSPITAL CARE^5^109
 ;;^UTILITY(U,$J,358.4,1273,0)
 ;;=HOSPITAL CARE DISCHARGE^7^109
 ;;^UTILITY(U,$J,358.4,1274,0)
 ;;=INITIAL OBSERVATION CARE^8^109
 ;;^UTILITY(U,$J,358.4,1275,0)
 ;;=OBSERVATION CARE DISCHARGE SERVICES^10^109
 ;;^UTILITY(U,$J,358.4,1276,0)
 ;;=INPT or ADMIT & DISCHARGE SAME DAY^11^109
 ;;^UTILITY(U,$J,358.4,1277,0)
 ;;=SUBSEQUENT HOSPITAL CARE^6^109
 ;;^UTILITY(U,$J,358.4,1278,0)
 ;;=OBSERVATION SUBSEQUENT CARE^9^109
 ;;^UTILITY(U,$J,358.4,1279,0)
 ;;=DOMICILIARY EST PATIENT^12^109
 ;;^UTILITY(U,$J,358.4,1280,0)
 ;;=DOMICILIARY NEW PATIENT^13^109
 ;;^UTILITY(U,$J,358.4,1281,0)
 ;;=HOME VISITS EST PATIENT^14^109
 ;;^UTILITY(U,$J,358.4,1282,0)
 ;;=HOME VISITS NEW PATIENT^15^109
 ;;^UTILITY(U,$J,358.4,1283,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^110
 ;;^UTILITY(U,$J,358.4,1284,0)
 ;;=ANXIETY DISORDERS^2^110
 ;;^UTILITY(U,$J,358.4,1285,0)
 ;;=BIPOLAR & RELATED DISORDERS^3^110
 ;;^UTILITY(U,$J,358.4,1286,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^110
 ;;^UTILITY(U,$J,358.4,1287,0)
 ;;=DEPRESSIVE DISORDERS^7^110
 ;;^UTILITY(U,$J,358.4,1288,0)
 ;;=DISSOCIATIVE DISORDERS ^9^110
 ;;^UTILITY(U,$J,358.4,1289,0)
 ;;=FEEDING & EATING DISORDERS^12^110
 ;;^UTILITY(U,$J,358.4,1290,0)
 ;;=EDUC/OCCUPATIONAL PROBLEMS^10^110
 ;;^UTILITY(U,$J,358.4,1291,0)
 ;;=GENDER DYSPHORIA^14^110
 ;;^UTILITY(U,$J,358.4,1292,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^110
 ;;^UTILITY(U,$J,358.4,1293,0)
 ;;=MEDICATION ADVERSE EFFECTS^16^110
 ;;^UTILITY(U,$J,358.4,1294,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^110
 ;;^UTILITY(U,$J,358.4,1295,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^110
 ;;^UTILITY(U,$J,358.4,1296,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^110
 ;;^UTILITY(U,$J,358.4,1297,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^110
 ;;^UTILITY(U,$J,358.4,1298,0)
 ;;=PARAPHILIC DISORDERS^21^110
 ;;^UTILITY(U,$J,358.4,1299,0)
 ;;=PERSONALITY DISORDERS^23^110
 ;;^UTILITY(U,$J,358.4,1300,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^110
 ;;^UTILITY(U,$J,358.4,1301,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^110
 ;;^UTILITY(U,$J,358.4,1302,0)
 ;;=RELATIONAL PROBLEMS^25^110
 ;;^UTILITY(U,$J,358.4,1303,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^110
 ;;^UTILITY(U,$J,358.4,1304,0)
 ;;=SEXUAL DYSFUNCTIONS^27^110
 ;;^UTILITY(U,$J,358.4,1305,0)
 ;;=SLEEP-WAKE DISORDERS^28^110
 ;;^UTILITY(U,$J,358.4,1306,0)
 ;;=SUBSTANCE DISORDER-ALCOHOL^31^110
 ;;^UTILITY(U,$J,358.4,1307,0)
 ;;=SUBSTANCE DISORDER-CANNABIS^33^110
 ;;^UTILITY(U,$J,358.4,1308,0)
 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^110
 ;;^UTILITY(U,$J,358.4,1309,0)
 ;;=SUBSTANCE DISORDER-OPIOID^36^110
 ;;^UTILITY(U,$J,358.4,1310,0)
 ;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^37^110
 ;;^UTILITY(U,$J,358.4,1311,0)
 ;;=SUBSTANCE DISORDER-TOBACCO^39^110
